BMRN vs UBER · P/E 40, rev $2.85B vs P/E 18, rev $52.02B
Biomarin Pharmaceutical Inc (BMRN) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the BMRN and UBER stock pages for the full models.
Not investment advice.